Got a short mention in todays Bulletin.Income so far for 03/04 is $1.2m and on target for their estimate of $1.8 for the year. Cash on hand $3m with a monthly cash burn of $300K and a probable share issue this year.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
